Evidence map›Paper›PMID 26229116›Full record

Trial reportScience (New York, N.Y.)2015

Growth dynamics of gut microbiota in health and disease inferred from single metagenomic samples.

Tal Korem, David Zeevi, Jotham Suez, Adina Weinberger, Tali Avnit-Sagi, Maya Pompan-Lotan, Elad Matot, Ghil Jona, Alon Harmelin, Nadav Cohen and 7 more

2 registry-linked trialsAbstract readClinical Trial
In one paragraph

Trial report in Science (New York, N.Y.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 257 papers.

0numbers the graph read from it
0cells of the map it votes in
257citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03009565 unknown statusnot on this mapstarted 2017, after this paper: background citation

Does the Human Gut Microbiome Serve as a Novel Personalized Therapeutic Target for Coronary Atherosclerosis?

TypeobservationalSponsorRabin Medical CenterRan2017 to 2019Enrolled800ConditionsCoronary (Artery) DiseaseArmscoronary artery disease
NCT03543644 nacompletednot on this mapstarted 2018, after this paper: background citation

A Randomized Controlled Trial of the Effect of Replacing Sugar-sweetened Beverages With Non-nutritive Sweetened Beverages or Water on Gut Microbiome and Metabolic Outcomes: STOP Sugars NOW Trial

TypeinterventionalSponsorUniversity of TorontoRan2018 to 2020Enrolled81ConditionsHealthy, Overweight and Obesity, Metabolic Syndrome, PreDiabetesArmsSugar-sweetened beverage (SSB), Non-nutritive sweetened beverages (NSB), Water
3 · Its place in the literature

Who cites it

257 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Geometric ordering in bacterial communities.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Multiplexed PCR to measureApplied and environmental microbiology · 2025
    Article

197 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Tal Korem *Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.
David Zeevi *Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.
Jotham Suez *Immunology Department, Weizmann Institute of Science, Rehovot, Israel.
Adina Weinberger *Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.
Tali Avnit-SagiDepartment of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.
Maya Pompan-LotanDepartment of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.
Elad MatotDepartment of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.
Ghil JonaDepartment of Biological services, Weizmann Institute of Science, Rehovot, Israel.
Alon HarmelinDepartment of Veterinary Resources, Weizmann Institute of Science, Rehovot, Israel.
Nadav CohenDepartment of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.
Alexandra Sirota-MadiCenter for Computational and Integrative Biology, Massachusetts General Hospital, Harvard Medical School and Broad Institute.
Christoph A ThaissImmunology Department, Weizmann Institute of Science, Rehovot, Israel.
Meirav Pevsner-FischerImmunology Department, Weizmann Institute of Science, Rehovot, Israel.
Rotem SorekDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
Ramnik XavierCenter for Computational and Integrative Biology, Massachusetts General Hospital, Harvard Medical School and Broad Institute.
Eran ElinavImmunology Department, Weizmann Institute of Science, Rehovot, Israel.
Eran SegalDepartment of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.

Funding

Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG · 1991 to 2026
$35.3M
NIDDK NIH HHS P30 DK043351
6 · The paper itself

Abstract

Metagenomic sequencing increased our understanding of the role of the microbiome in health and disease, yet it only provides a snapshot of a highly dynamic ecosystem. Here, we show that the pattern of metagenomic sequencing read coverage for different microbial genomes contains a single trough and a single peak, the latter coinciding with the bacterial origin of replication. Furthermore, the ratio of sequencing coverage between the peak and trough provides a quantitative measure of a species' growth rate. We demonstrate this in vitro and in vivo, under different growth conditions, and in complex bacterial communities. For several bacterial species, peak-to-trough coverage ratios, but not relative abundances, correlated with the manifestation of inflammatory bowel disease and type II diabetes.

Indexed as

BacteriaDiabetes Mellitus, Type 2Gastrointestinal TractGenome, BacterialHumansInflammatory Bowel DiseasesMetagenomeMetagenomicsMicrobiota

Identifiers

PMID26229116
PMCPMC5087275

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.